Ozempic and other GLP-1 drugs have easily become one of the hottest topics in healthcare, especially because they have a ...

Though retrospective, the findings provide ‘compelling’ evidence that GLP-1 receptor agonists may help prevent development ...

The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.

Attorney James Gourley details the many legal issues surrounding the GLP-1 drug market and offers advice to companies on how ...

Nationally representative survey data revealed that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) use for obesity ...

A new study from the Karolinska Institutet in Sweden has found that a common type of diabetes medicine might also help ...

The use of GLP-1s among patients with type 2 diabetes appeared associated with significantly reduced risk for certain ...

New findings from multiple studies demonstrate that glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of ...

As more people take GLP-1 medications for weight loss ... Tonya Curry is a registered dietitian and diabetes counselor at Piedmont Healthcare. She says right now, she’s booking appointments ...

Yet the disparities by sex, race/ethnicity, and location pale in comparison to a striking overall lack of adoption.